TCR Therapy: A Next Generation Cancer Treatment
T cell receptor (TCR) therapy is an emerging type of immunotherapy that harnesses the power of T cells to fight cancer. Instead of working with a patient's native T cells, as CAR-T therapy does, TCR therapy transfers genetically engineered T cells that have been modified to target specific tumor antigens. By redirecting T cells to recognize and kill cancer cells, therapy shows great potential as a targeted treatment against a wide range of cancers. Workings T cells play a key role in the immune system's defense against cancer and other diseases. However, tumors have developed ways to evade detection by T cells. In this TCR therapy , T cells are extracted from a patient's blood and modified in the laboratory. The genes that code for the native T cell receptors are replaced with genes encoding tumor-targeting TCRs. These engineered TCRs allow the modified T cells to recognize specific peptide fragments presented on cancer cells by MHC molecules. Once re-infused into the ...